Pembrolizumab before and after melanoma surgery boosts outcomesMarch 7, 2023MelanomaDermatologyOncology
Be vigilant about suspected cases of measles, expert advisesMarch 7, 2023Infectious DiseasesDermatologyVaccines
What’s holding back physicians from prescribing biosimilars? Four specialties weigh inFebruary 23, 2023Business of MedicineDermatology
Expert discusses pros, cons of molecular tests for melanomaFebruary 21, 2023MelanomaDermatologyOncology
More than 97K new cutaneous melanoma diagnoses expected in 2023February 14, 2023MelanomaDermatologyOncology
Elevated PCSK9 levels associated with psoriasis suggest new treatment targetJanuary 30, 2023CardiologyDermatology
Best estimates made for hydroxychloroquine retinopathy riskJanuary 18, 2023DermatologyInfectious Diseases
Melanoma mortality rates fell in 2010s as new therapies took holdDecember 12, 2022MelanomaDermatologyOncology
